EE326 Health Care Resource Utilization and Costs Among Patients with Paroxysmal Nocturnal Hemoglobinuria Initiating Eculizumab and Ravulizumab: A U.S. Claims Analysis

Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.625
https://www.valueinhealthjournal.com/article/S1098-3015(24)00740-X/fulltext
Section Title :
Section Order : 10100
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00740-X&doi=10.1016/j.jval.2024.03.625
HEOR Topics :
Tags :
Regions :